Literature DB >> 19652437

An unusual case of chronic relapsing tetanus associated with mandibular osteomyelitis.

Yasuhito Wakasaya1, Mitsunori Watanabe, Masahiko Tomiyama, Chieko Suzuki, Mandy Jackson, Masahiro Fujimuro, Tamaki Kimura, Yusuke Seino, Takeshi Kawarabayashi, Yukiko Yamamoto-Watanabe, Etsuro Matsubara, Ikumi Shirahama, Ayumi Takamura, Naoko Nakahata, Mikio Shoji.   

Abstract

A 55-year-old man underwent radiation therapy due to malignant lymphoma of the neck. Eight years after the therapy he developed tetanus. It appears that the radiation therapy resulted in mandibular necrosis, and that this lesion may have been the infectious focus of tetanus. Treatment with penicillin G was very effective in the acute stage, and chronic administration of metronidazole prevented relapse of the disease. However in spite of injections of tetanus toxoid, symptoms of tetanus returned when the administration of metronidazole was discontinued because the infectious focus could not be completely removed. This is the first report of chronic relapsing tetanus associated with radiation-induced mandibular osteomyelitis, and demonstrates that tetanus can occur due to mandibular focus but the chronic administration of metronidazole can prevent relapse.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652437     DOI: 10.2169/internalmedicine.48.2136

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  Clostridium tetani osteitis without tetanus.

Authors:  Pierre-Yves Levy; Pierre-Edouard Fournier; Laurène Lotte; Matthieu Million; Philippe Brouqui; Didier Raoult
Journal:  Emerg Infect Dis       Date:  2014-09       Impact factor: 6.883

Review 2.  Non-surgical treatment of tetanus infection associated with breast cancer skin ulcer: a case report and literature review.

Authors:  Kazuhito Nomura; Eiji Sakawaki; Sonoko Sakawaki; Ayumu Yamaoka; Wakiko Aisaka; Hiroyuki Okamoto; Yoshihiro Takeyama; Shuji Uemura; Eichi Narimatsu
Journal:  BMC Infect Dis       Date:  2021-01-07       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.